dobutamin hameln 5 mg/ml infúzny roztok
hameln pharma gmbh, nemecko - dobutamín - 41 - cardiaca
furosemid medreg
medreg s.r.o., Česká republika - furosemid - 50 - diuretica
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyóm - hypofýzové a hypotalamické hormóny a analógy - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
fentanyl kalceks 50 mikrogramov/ml injekčný roztok
as kalceks, lotyšsko - fentanyl - 65 - analgetica - anodyna
rollwet
adama - od - polyalkylén oxid modifikovaného heptametyltrisiloxánu 204 g/l, + blok kopolymérov etylén oxidu a propylén oxidu 832 g/l, - adjuvanty, regulátory rastu a biostimulanty
velocity
adama - ec - methylester repkového oleja 744.5 g/l, + polyether-polymethylsiloxan-kopolymer 103.3 g/l, - adjuvanty, regulátory rastu a biostimulanty
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - iné alimentárny trakt a metabolizmus výrobky, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
vydura
pfizer europe ma eeig - rimegepant - poruchy migrény - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
scemblix
novartis europharm limited - asciminib hydrochloride - leukémia, myelogénna, chronická, bcr-abl pozitívna - antineoplastické činidlá - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.